Spots Global Cancer Trial Database for pineoblastoma
Every month we try and update this database with for pineoblastoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Morphological Analysis of the Pineal Gland in Pediatric Retinoblastoma Patients Using Magnetic Resonance Imaging | NCT01884194 | Retinoblastoma Pineoblastoma | 1 Day - 50 Years | Charite University, Berlin, Germany | ||
| Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System | NCT04743310 | Central Nervous... | tozuleristide Canvas imaging ... Surgical resect... | 18 Years - | Cedars-Sinai Medical Center | |
| Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome | NCT00565903 | Pleuropulmonary... Cystic Nephroma Sertoli-Leydig ... Medulloepitheli... Embryonal Rhabd... Goiter Sarcoma Pineoblastoma Pituitary Tumor... Wilms Tumor | 1 Day - 95 Years | Children's National Research Institute | ||
| Morphological Analysis of the Pineal Gland in Pediatric Retinoblastoma Patients Using Magnetic Resonance Imaging | NCT01884194 | Retinoblastoma Pineoblastoma | 1 Day - 50 Years | Charite University, Berlin, Germany | ||
| International PPB/DICER1 Registry | NCT03382158 | Pleuropulmonary... Sertoli-Leydig ... DICER1 Syndrome Cystic Nephroma Wilms Tumor Pineoblastoma Renal Sarcoma Nodular Hyperpl... Nasal Chondrome... Ciliary Body Me... Neuroblastoma Pituitary Cance... Embryonal Rhabd... Ovarian Sarcoma Gynandroblastom... Thyroid Carcino... Embryonal Rhabd... Embryonal Rhabd... Embryonal Rhabd... | - | Children's Hospitals and Clinics of Minnesota | ||
| Prospective Pilot Trial to Assess a Multimodal Molecular Targeted Therapy in Children, Adolescent and Young Adults With Relapsed or Refractory High-grade Pineoblastoma | NCT02596828 | Pineoblastoma | Temozolomide Irinotecan Dasatinib Rapamycin | 0 Years - 25 Years | University of Regensburg | |
| Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System | NCT00867178 | Medulloblastoma Pineoblastoma Supratentorial ... | 3-Dimensional C... Carboplatin Cisplatin Cyclophosphamid... Etoposide Phosp... Isotretinoin Laboratory Biom... Peripheral Bloo... Thiotepa Vincristine Sul... Vorinostat | 2 Months - 47 Months | National Cancer Institute (NCI) | |
| Prospective Pilot Trial to Assess a Multimodal Molecular Targeted Therapy in Children, Adolescent and Young Adults With Relapsed or Refractory High-grade Pineoblastoma | NCT02596828 | Pineoblastoma | Temozolomide Irinotecan Dasatinib Rapamycin | 0 Years - 25 Years | University of Regensburg | |
| A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors | NCT06357377 | Pediatric Tumor... Pediatric Tumor... Diffuse Midline... Pediatric Tumor... Pineocytoma Choroid Plexus ... Spinal Cord Tum... High Grade Glio... | NEO100 | 5 Years - 18 Years | Neonc Technologies, Inc. | |
| International PPB/DICER1 Registry | NCT03382158 | Pleuropulmonary... Sertoli-Leydig ... DICER1 Syndrome Cystic Nephroma Wilms Tumor Pineoblastoma Renal Sarcoma Nodular Hyperpl... Nasal Chondrome... Ciliary Body Me... Neuroblastoma Pituitary Cance... Embryonal Rhabd... Ovarian Sarcoma Gynandroblastom... Thyroid Carcino... Embryonal Rhabd... Embryonal Rhabd... Embryonal Rhabd... | - | Children's Hospitals and Clinics of Minnesota | ||
| Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors | NCT01217437 | Central Nervous... Pineoblastoma Recurrent Medul... Recurrent Primi... Refractory Medu... Refractory Peri... | Bevacizumab Irinotecan Hydr... Temozolomide | - 21 Years | National Cancer Institute (NCI) | |
| Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors | NCT02574728 | Cancer | Sirolimus Celecoxib Etoposide Cyclophosphamid... | 12 Months - 30 Years | Emory University | |
| Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System | NCT04743310 | Central Nervous... | tozuleristide Canvas imaging ... Surgical resect... | 18 Years - | Cedars-Sinai Medical Center | |
| Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors | NCT02095132 | Central Nervous... Central Nervous... Central Nervous... Embryonal Tumor... Pineoblastoma Primary Central... Recurrent Child... Recurrent Malig... Recurrent Medul... Recurrent Neuro... Recurrent Rhabd... Refractory Mali... Refractory Medu... Refractory Neur... Refractory Rhab... | Adavosertib Irinotecan Hydr... | 1 Year - 21 Years | National Cancer Institute (NCI) | |
| Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome | NCT00565903 | Pleuropulmonary... Cystic Nephroma Sertoli-Leydig ... Medulloepitheli... Embryonal Rhabd... Goiter Sarcoma Pineoblastoma Pituitary Tumor... Wilms Tumor | 1 Day - 95 Years | Children's National Research Institute | ||
| StrataXRT in Preventing Radiation Dermatitis in Pediatric Patients Undergoing Radiation Therapy to the Brain or Spinal Cord | NCT03990597 | Central Nervous... Ependymoma Glioma Malignant Intra... Medulloblastoma Pineoblastoma Primary Central... | Placebo Adminis... Questionnaire A... Wound Dressing ... | 2 Years - 17 Years | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
